Mediterr J Rheumatol 2016;27(2):48-54
Body-size phenotypes and cardiometabolic risk in Rheumatoid Arthritis (Short Title: Subgroups of obesity in RA)
Authors Information

1: Department of Sport and Exercise Science, University of Thessaly, Trikala, Greece

2: Institute of Human Performance & Rehabilitation, Centre for Research and Technology Thessaly, Trikala, Greece

3: Department of Rheumatology, Dudley Group NHS Foundation Trust, Russell’s Hall Hospital, Dudley, West Midlands, UK

4: School of Sport, Performing Arts & Leisure, Wolverhampton University, West Midlands, UK

5: Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, UK

  1. Wildman R P, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-24.
  2. Karelis A D, St-Pierre D H, Conus F, Rabasa-Lhoret R, Poehlman E T. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-75.
  3. Sims E A. Are there persons who are obese, but metabolically healthy? Metabolism 2001;50:1499-1504.
  4. Ruderman N, Schneider S, Berchtold P. The "metabolically-obese," normal-weight individual. Am J Clin Nutr 1981;34:1617-21.
  5. Ruderman N B, Berchtold P, Schneider SH. Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes 1982;6:151-7.
  6. Kitas G D, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 2003;42:607-13.
  7. Stavropoulos-Kalinoglou A, Metsios G S, Koutedakis Y, Nevill A M, Douglas K M, Jamurtas A, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis 2007;66:1316-21.
  8. Westhoff G, Rau R, Zink A. Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthritis Rheum 2007;56:3575-82.
  9. van der Helm-van Mil A H, van der Kooij S M, Allaart C F, Toes R E, Huizinga T W. A high body mass index is protective on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis 2008;67:769-74.
  10. Escalante A, Haas R W, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005;165:1624-9.
  11. Stavropoulos-Kalinoglou A, Metsios G S, Panoulas V F, Nevill A M, Jamurtas A Z, Koutedakis Y, et al. Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol 2009;28:439-44.
  12. Stavropoulos-Kalinoglou A, Metsios G S, Panoulas V F, Douglas K M, Nevill A M, Jamurtas A Z, et al. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 2009;68:242-5.
  13. Garcia-Poma A, Segami M I, Mora C S, Ugarte M F, Terrazas H N, Rhor E A, et al. Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis. Clin Rheumatol 2007;26:1831-5.
  14. Stavropoulos-Kalinoglou A, Metsios G S, Koutedakis Y, Kitas G D. Obesity in rheumatoid arthritis. Rheumatology (Oxford) 2011;50:450-62.
  15. Panoulas V F, Douglas K M, Milionis H J, Stavropoulos-Kalinglou A, Nightingale P, Kita M D, et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 2007;46:1477-82.
  16. Lean M E J, Han T S, Morrison C E. Waist circumference as a measure for indicating need for weight management. BMJ 1995;311:158-61.
  17. Prevoo M L, van 't Hof M A, Kuper H H, van Leeuwen M A, van de Putte L B, van Riel P L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
  18. Kirwan J R, Reeback J S. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986;25:206-9.
  19. Radikova Z. Assessment of insulin sensitivity/resistance in epidemiological studies. Endocr Regul 2003;37:189-94.
  20. Katz A, Nambi S S, Mather K, Baron A D, Follmann D A, Sullivan G, et al. Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans. J Clin Endocrinol Metab 2000;85:2402-10.
  21. Kramer C K, Zinman B, Retnakaran R. Are Metabolically Healthy Overweight and Obesity Benign Conditions? A Systematic Review and Meta-analysis. Ann Int Med 2013;159:758-69.
  22. Zheng R, Zhou D, Zhu Y. The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis. J Epidemiol Community Health 2016;70(10):1024-31.
  23. Roubenoff R. Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century. Arthritis Res Ther 2009;11:108.
  24. Summers G D, Metsios G S, Stavropoulos-Kalinoglou A, Kitas G D. Rheumatoid cachexia and cardiovascular disease. Nature Rev 2010;6:445-51.
  25. Grundy S M, Brewer H B, Cleeman J I, Smith S C, Lenfant C, American Heart Association; National Heart, Lung, and Blood Institute. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8.
  26. Derdemezis C S, Voulgari P V, Drosos A A, Kiortsis D N. Obesity, adipose tissue and rheumatoid arthritis: coincidence or more complex relationship? Clin Exp Rheumatol 2011;29:712-27.
  27. Freedland E S. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond) 2004;1:12.
  28. Bhagat K, Vallance P. Inflammatory Cytokines Impair Endothelium-Dependent Dilatation in Human Veins In Vivo. Circulation 1997;96:3042-7.
  29. Alexander R W. Hypertension and the Pathogenesis of Atherosclerosis: Oxidative Stress and the Mediation of Arterial Inflammatory Response: A New Perspective. Hypertension 1995;25:155-61.
  30. Rizzoni D. Endothelial dysfunction in hypertension: fact or fantasy? J Hypertens 2002;20:1479-81.
  31. Ross R. Atherosclerosis -- An Inflammatory Disease. N Engl J Med 1999;340:115-26.
  32. Stavropoulos-Kalinoglou A, Metsios G S, Panoulas V F, Douglas K M, Nevill A M, Jamurtas A Z, et al. Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study. Arthritis Res Ther 2008;10:R59.
  33. Barbieri M, Gambardella A, Paolisso G, Varricchio M. Metabolic aspects of the extreme longevity. Exp Gerontol 2008;43:74-8.
  34. Barbieri M, Rizzo M R, Manzella D, Paolisso G. Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians. Diabetes Metab Res Rev 2001;17:19-26.
  35. Dimitroulas T, Sandoo A, van Zanten J V, Smith J P, Hodson J, Metsios G S, et al. Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance. Scand J Rheumatol 2013;42:176-81.
  36. Flegal K M, Kit B K, Orpana H, Graubard B I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. JAMA 2013;309:71-82.